Cargando…

Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome

INTRODUCTION: Young age is an adverse prognostic factor in children with ependymomas. Treatment of these infants is challenging since beneficial therapeutic options are limited. As ependymomas are considered a biologically heterogeneous group, we aimed to characterize infant ependymomas with regard...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jünger, Stephanie T., Andreiuolo, Felipe, Mynarek, Martin, Dörner, Evelyn, zur Mühlen, Anja, Rutkowski, Stefan, von Bueren, Andre O., Pietsch, Torsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575464/ https://www.ncbi.nlm.nih.gov/pubmed/32474813 http://dx.doi.org/10.1007/s00381-020-04655-x

Ejemplares similares

EPEN-27. CDKN2A DELETION IN SUPRATENTORIAL EPENDYMOMA WITH RELA ALTERATION INDICATES A DISMAL PROGNOSIS – A RETROSPECTIVE ANALYSIS OF THE HIT EPENDYMOMA TRIAL COHORT
por: Jünger, Stephanie T, et al.
Publicado: (2020)

CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2020)

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohort
por: Jünger, Stephanie T., et al.
Publicado: (2019)

Supratentorial ependymoma in childhood: more than just RELA or YAP
por: Zschernack, Valentina, et al.
Publicado: (2021)

MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

Pediatric ependymoma: an overview of a complex disease
por: Jünger, Stephanie Theresa, et al.
Publicado: (2021)

Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype
por: Kresbach, Catena, et al.
Publicado: (2021)

Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification
por: Andreiuolo, Felipe, et al.
Publicado: (2017)

Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features
por: Andreiuolo, Felipe, et al.
Publicado: (2018)

YAP1/TAZ drives ependymoma-like tumour formation in mice
por: Eder, Noreen, et al.
Publicado: (2020)

Author Correction: YAP1/TAZ drives ependymoma-like tumour formation in mice
por: Eder, Noreen, et al.
Publicado: (2020)

Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
por: Adolph, Jonas E., et al.
Publicado: (2021)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

SDPS-27 P16 IMMUNOHISTOCHEMISTRY AS A SCREENING TOOL FOR HOMOZYGOUS CDKN2A DELETIONS IN GLIAL TUMORS
por: Zschernack, Valentina, et al.
Publicado: (2023)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Tanycytic Ependymoma: A Challenging Histological Diagnosis
por: Krisht, Khaled M., et al.
Publicado: (2013)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

EPEN-09. IMPACT OF MOLECULAR SUBGROUP ON OUTCOME FOR INFANTS <12 MONTHS WITH INTRACRANIAL EPENDYMOMA - GERMAN EXPERIENCE FROM HIT2000, INTERIM-2000-REGISTRY AND I-HIT-MED REGISTRY
por: Obrecht, Denise, et al.
Publicado: (2020)

Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma
por: Rousseau, Emmanuel, et al.
Publicado: (2007)

HGG-34. DETECTION OF ONCOGENIC FUSION EVENTS IN SUPRATENTORIAL GLIOBLASTOMAS OF YOUNG CHILDREN
por: Pietsch, Torsten, et al.
Publicado: (2020)

EPEN-39. CLINICAL STRATIFIED TREATMENT OF LOCALIZED PEDIATRIC INTRACRANIAL EPENDYMOMA WITH COMBINED LOCAL IRRADIATION AND CHEMOTHERAPY WITHIN THE PROSPECTIVE, MULTICENTER E-HIT TRIAL – THE MOLECULAR SUBGROUP MATTERS
por: von Hoff, Katja, et al.
Publicado: (2020)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022)

Aggressive histologic features do not predict biologic behavior in melanotic neuroectodermal tumor of infancy
por: Marschall, Jeffrey S, et al.
Publicado: (2018)

HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
por: Pietsch, Torsten, et al.
Publicado: (2022)

MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma
por: Obrecht, Denise, et al.
Publicado: (2022)

MEDB-16. Persistent radiological lesions at the end of primary therapy in childhood medulloblastoma: residual lesion or active residual tumor?
por: Schömig, Lena, et al.
Publicado: (2022)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

QOL-04. Histology, treatment, and extent of pretreatment hydrocephalus are major determents of neurocognitive outcome for survivors of pediatric posterior fossa tumors - report from the German HIT-studies
por: Neumann-Holbeck, Anne, et al.
Publicado: (2022)

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma
por: Ng, Chia Huan, et al.
Publicado: (2023)

Myxopapillary ependymoma: Lesser known cytomorphologic features
por: Choudhury, Monisha, et al.
Publicado: (2015)

An Insight into Pathophysiological Features and Therapeutic Advances on Ependymoma
por: Seo, Seung-Hee, et al.
Publicado: (2021)

Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort
por: Kloth, Katja, et al.
Publicado: (2021)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Intraoperative squash cytology and histology of giant cell ependymoma: A diagnostic dilemma
por: Cakir, Ebru, et al.
Publicado: (2017)

Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg Study
por: Peters, Sarah, et al.
Publicado: (2021)

Ependymomas
por: Bertero, Luca, et al.
Publicado: (2022)

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment
por: Ottensmeier, Holger, et al.
Publicado: (2020)

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial
por: Clifford, Steven C., et al.
Publicado: (2015)

Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis
por: Peyre, Matthieu, et al.
Publicado: (2010)

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts
por: Ellison, David W, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e2ergat78fgcu5ba539ernncj6